mOm Incubators Receives FDA Clearance for First-of-Its-Kind Portable Incubator for Premature Babies
Unique, easy-to-use, lightweight incubator enables care anywhere and everywhere while avoiding separation of mother and baby
Potential for novel incubator to address key aspects of preterm neonatal care and reduce dependence on NICU
NOTTINGHAM, England–(BUSINESS WIRE)–mOm Incubators Limited announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the company’s mOm Essential Incubator, a first-of-its-kind portable incubator that provides thermoregulation for premature babies, to market the device in the United States. The novel design of the mOm Essential Incubator enables it to be used anywhere and everywhere, and enables mother and baby to stay together, reducing parental stress and improving health outcomes. mOm Incubators Limited will work with Health Care Providers (HCPs) to deploy mOm Essential Incubators across a range of labor and delivery settings across the United States, enabling more rapid access to neonatal care and maintaining the closeness of newborn and mother.
